Genomics Market Global Report 2020-30 from the author provides the strategists, marketers and senior management with the critical information they need to assess the global genomics market.
Reasons to Purchase
Description:
Where is the largest and fastest growing market for the genomics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Genomics market global report from the author answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider genomics market, and compares it with other markets.
Scope
Markets Covered: 1) By Product Type: Instrument (Including Systems, Service Contract And Software); Reagents (Including Reagents And Consumables); 2) By Process: Cell Isolation; Sample Preparation; Genomic Analysis; 3) By End User: Academic Institutes; Biopharmaceutical Companies; Clinical Research Institutes
Companies Mentioned: 10X Genomics; Qiagen NV; Fluidigm Corporation; Johnson & Johnson Private Limited; Zephyrus Biosciences Inc.
Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:
Where is the largest and fastest growing market for the genomics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Genomics market global report from the author answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider genomics market, and compares it with other markets.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
- The genomics market section of the report gives context. It compares the genomics market with other segments of the genomics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, genomics indicators comparison.
Scope
Markets Covered: 1) By Product Type: Instrument (Including Systems, Service Contract And Software); Reagents (Including Reagents And Consumables); 2) By Process: Cell Isolation; Sample Preparation; Genomic Analysis; 3) By End User: Academic Institutes; Biopharmaceutical Companies; Clinical Research Institutes
Companies Mentioned: 10X Genomics; Qiagen NV; Fluidigm Corporation; Johnson & Johnson Private Limited; Zephyrus Biosciences Inc.
Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1. Executive Summary2. Genomics Market Characteristics26. Key Mergers And Acquisitions In The Genomics Market27. Genomics Market Trends And Strategies28. Genomics Market Future Outlook and Potential Analysis
3. Genomics Market Size And Growth
4. Genomics Market Segmentation
5. Genomics Market Regional And Country Analysis
6. Asia-Pacific Genomics Market
7. China Genomics Market
8. India Genomics Market
9. Japan Genomics Market
10. Australia Genomics Market
11. Indonesia Genomics Market
12. South Korea Genomics Market
13. Western Europe Genomics Market
14. UK Genomics Market
15. Germany Genomics Market
16. France Genomics Market
17. Eastern Europe Genomics Market
18. Russia Genomics Market
19. North America Genomics Market
20. USA Genomics Market
21. South America Genomics Market
22. Brazil Genomics Market
23. Middle East Genomics Market
24. Africa Genomics Market
25. Genomics Market Competitive Landscape And Company Profiles
29. Appendix
Executive Summary
The genomics market consists of sales of single-cell genomics and related goods. The study of genomes is called genomics. Single-cell genomics is an innovative method of classifying individual cells from a tissue sample, capable of defining unique traits and identifying rare cell types. Genomics is used in different fields of study such as intragenomic phenomenon including pleiotropy, epistasis, heterosis, and other interactions between loci and alleles within the genome.The global genomics market was worth $851.96 million in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 14.71% and reach $1475.11 million by 2023.
The genomics market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. North America was the largest region in 2019.
The genomics market covered in this report is segmented by product type into instrument (including systems, service contract and software), reagents (including reagents and consumables). It is also segmented by process into cell isolation, sample preparation, genomic analysis and by end user into academic institutes, biopharmaceutical companies, clinical research institutes.
Rising government funds for research on genomics drives the growth of the single-cell genomics market. The government funding focuses on efforts to resolve the complexity of the human genome, define the genomic basis of human health and disease, and ensure that genomics is used safely to enhance patient care and benefit society through government, public and private institutions. For instance, in 2018, in the U.S, The All of Us Research Program, a part of the National Institutes of Health, gave funds of $28.6 million for establishing three genome centers in the USA. These centers will start generating genomic data from the biosamples contributed by the participants of the program.
The technology limitation in single-cell genomics hinders the growth of the single-cell genomics market. Due to cost and technical constraints, the use of genetic sequencing to better target and treat rare and chronic diseases was largely out of reach for most health care organizations. Therefore, limiting the market’s growth.
Companies are investing in new product launches to increase their revenue and expand their consumer base and also for gaining a competitive edge over their rivals. For instance, in 2018, NanoString Technologies, Inc., a USA-based biotech company, specialized in developing cancer diagnostics tools launched a CAR-T characterization panel, a new gene expression panel for the molecular characterization of CAR-T cells in research, development, and manufacturing. The panel was developed in partnership with eight leading CAR-T therapy centers and helps in ease of workflow and aims to advance the field of CAR-T therapy.
In November 2019, Exact Sciences Corp., a USA-based molecular diagnostics company specialized in colon cancer screening, screening test research, and development, non-invasive cancer screening for early detection and prevention of colorectal cancer, acquired Genomic Health Inc. for $2.8 billion in cash. The acquisition is expected to help Exact Sciences Corp. to broaden its offering of cancer tests and expand its footprint in more than 90 countries. Genomic Health Inc. is a USA-based life science company that specializes in the development of genomic-based clinical diagnostic tests for cancer.
Major players in the market are 10X Genomics, Qiagen NV, Fluidigm Corporation, Johnson & Johnson Private Limited, Zephyrus Biosciences Inc., Illumina, Inc., Affymetrix, Angle PLC, Denovo Sciences Inc. and Diagnologix LLC.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 10X Genomics
- Qiagen NV
- Fluidigm Corporation
- Johnson & Johnson Private Limited
- Zephyrus Biosciences Inc.
- Illumina, Inc.
- Affymetrix
- Angle PLC
- Denovo Sciences Inc.
- Diagnologix llc
- DNA Electronics Ltd
- Enumeral
- Epic Sciences
- Kellbenx Inc.
- Resolution Bio Science Inc.
- Wafergen Bio-systems Inc.
- Yikon Genomics Co. Ltd
- Thermo Fisher Scientific Inc.
- CellBio
- Beckman Coulter
- Becton Dickinson
- Bio-Rad
- Carl Zeiss Microscopy
- Cell Microsystems
- Cellsee Diagnostics
- CellSorter
- Cytena
- CytoTrack
- Dolomite Bio
- Agilent Technologies Inc.
- Fluxion Biosciences
Methodology
LOADING...
